LY2562175
| CAS号 | 1103500-20-4 | 货号 | BCP33226 |
| 中文名 | LY2562175 | ||
| 英文名 | LY2562175 | ||
| 中文别名 | |||
| 英文别名 | LY 2562175; LY-2562175; | ||
| 分子式 | C28H27Cl2N3O4 | 分子量 | 540.44 |
| 生物活性 | LY2562175 is a potent and selective FXR agonist in vitro and has robust lipid modulating properties, lowering LDL and triglycerides while raising HDL in preclinical species. The preclinical ADME properties of LY2562175 were consistent with enabling once daily dosing in humans, and it was ultimately advanced to the clinic for evaluation in humans. LY2562175 promotes transcriptional activation of human FXR in a cell-based cotransfection assay with an EC50 of 193 nM (geometric mean). | ||
| 信号通路 | Protease/Metabolic Enzyme | ||
| 靶 点 | FXR | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！